Subscribe
shutterstock_1123869875-servickuz
Servickuz / Shutterstock.com
27 October 2020BiotechnologyJoachim Wachenfeld and Florian Grasser

A stricter interpretation: the EPO and antibodies

The invention of the antibody hybridoma technology by Nobel prize winners Georges Köhler and César Milstein in 1975 paved the way to the development of therapeutic antibodies.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotechnology
EPO’s new examination guidelines: what you need to know
6 April 2021   The updated rules included important changes involving amino or nucleic acid sequences and antibodies, as Clare Roskell and Samantha Moodie of Mathys & Squire explain.
Americas
Danish university sues Creative Biolabs over ‘antibody pirating’
9 December 2020   The University of Southern Denmark has accused biotech Creative Biolabs of infringing its patent-protected monoclonal antibody, HG-HYB 7-5.
Big Pharma
Medical tech leads 2020 innovation at the EPO
16 March 2021   Healthcare innovation led patenting activity in 2020 as COVID-19 fuelled a rise in applications, a report by the European Patent Office has revealed.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Biotechnology
EPO’s new examination guidelines: what you need to know
6 April 2021   The updated rules included important changes involving amino or nucleic acid sequences and antibodies, as Clare Roskell and Samantha Moodie of Mathys & Squire explain.
Americas
Danish university sues Creative Biolabs over ‘antibody pirating’
9 December 2020   The University of Southern Denmark has accused biotech Creative Biolabs of infringing its patent-protected monoclonal antibody, HG-HYB 7-5.
Big Pharma
Medical tech leads 2020 innovation at the EPO
16 March 2021   Healthcare innovation led patenting activity in 2020 as COVID-19 fuelled a rise in applications, a report by the European Patent Office has revealed.

More on this story

Biotechnology
EPO’s new examination guidelines: what you need to know
6 April 2021   The updated rules included important changes involving amino or nucleic acid sequences and antibodies, as Clare Roskell and Samantha Moodie of Mathys & Squire explain.
Americas
Danish university sues Creative Biolabs over ‘antibody pirating’
9 December 2020   The University of Southern Denmark has accused biotech Creative Biolabs of infringing its patent-protected monoclonal antibody, HG-HYB 7-5.
Big Pharma
Medical tech leads 2020 innovation at the EPO
16 March 2021   Healthcare innovation led patenting activity in 2020 as COVID-19 fuelled a rise in applications, a report by the European Patent Office has revealed.

More features

Sarepta wins $115M in patent dispute over muscular dystrophy drug
CREATES Act unfairly tips the scales to generics
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York
Judge denies Intellia bid to throw out suit over $100m Regeneron pact
Trump’s return sparks calls for pro-patent agenda
Amgen faces pushback over bid to narrow patent scope
LSPN Europe: Navigating the EPO and lessons from the UPC frontline